Histone Modifications Associated with Somatic Hypermutation

Slides:



Advertisements
Similar presentations
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Advertisements

Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Volume 41, Issue 5, Pages (November 2014)
Volume 30, Issue 5, Pages (May 2009)
Nienke van der Stoep, James R Gorman, Frederick W Alt  Immunity 
Volume 28, Issue 3, Pages (November 2007)
Volume 19, Issue 4, Pages (August 2005)
Developmental- and differentiation-specific patterns of human γ- and β-globin promoter DNA methylation by Rodwell Mabaera, Christine A. Richardson, Kristin.
Volume 15, Issue 5, Pages (November 2001)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 47, Issue 2, Pages (July 2012)
Volume 3, Issue 4, Pages (October 2008)
Volume 7, Issue 6, Pages (December 1997)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Volume 55, Issue 1, Pages (July 2014)
Steven J. Petesch, John T. Lis  Cell 
Volume 7, Issue 1, Pages (July 2010)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development  Na Xiong, Chulho Kang, David H Raulet 
Volume 38, Issue 4, Pages (April 2013)
Volume 35, Issue 4, Pages (October 2011)
Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV- Induced Decrease of Type I Procollagen Expression  Min-Kyoung Kim,
Volume 29, Issue 2, Pages (February 2008)
Volume 22, Issue 4, Pages (May 2006)
Histone Modifications Associated with Somatic Hypermutation
Volume 42, Issue 3, Pages (March 2015)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Volume 28, Issue 3, Pages (March 2008)
Volume 18, Issue 6, Pages (December 2010)
Joseph Rodriguez, Jerome S. Menet, Michael Rosbash  Molecular Cell 
Volume 34, Issue 1, Pages (January 2011)
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Daniel F. Tardiff, Scott A. Lacadie, Michael Rosbash  Molecular Cell 
Volume 7, Issue 9, Pages (September 2014)
Volume 27, Issue 1, Pages (July 2007)
Volume 35, Issue 4, Pages (October 2011)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 19, Issue 1, Pages (January 2014)
Andrew W Snowden, Philip D Gregory, Casey C Case, Carl O Pabo 
Volume 25, Issue 2, Pages (August 2006)
Volume 47, Issue 4, Pages (August 2012)
Volume 39, Issue 6, Pages (December 2013)
Volume 30, Issue 1, Pages (January 2009)
Volume 28, Issue 4, Pages (April 2008)
Volume 24, Issue 5, Pages (May 2006)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
Volume 21, Issue 1, Pages (January 2011)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 1, Pages (July 2007)
FOXP3+CD25− Tumor Cells with Regulatory Function in Sézary Syndrome
Epigenetic Control of the S100A6 (Calcyclin) Gene Expression
Volume 21, Issue 6, Pages (December 2004)
Volume 31, Issue 6, Pages (December 2009)
Volume 27, Issue 5, Pages (September 2007)
Volume 32, Issue 5, Pages (May 2010)
Volume 32, Issue 5, Pages (December 2008)
Volume 24, Issue 4, Pages (April 2006)
Volume 33, Issue 1, Pages (July 2010)
Volume 21, Issue 6, Pages (December 2004)
Volume 8, Issue 2, Pages (August 2001)
Volume 31, Issue 6, Pages (December 2009)
Volume 9, Issue 3, Pages (November 2014)
Volume 29, Issue 5, Pages (November 2008)
Volume 39, Issue 5, Pages (November 2013)
Volume 28, Issue 5, Pages (May 2008)
Regulation of TCRβ Gene Assembly by a Promoter/Enhancer Holocomplex
Georgina Berrozpe, Gene O. Bryant, Katherine Warpinski, Mark Ptashne 
Presentation transcript:

Histone Modifications Associated with Somatic Hypermutation Valerie H. Odegard, Sean T. Kim, Shannon M. Anderson, Mark J. Shlomchik, David G. Schatz  Immunity  Volume 23, Issue 1, Pages 101-110 (July 2005) DOI: 10.1016/j.immuni.2005.05.007 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Isolation and Characterization of NP-Specific Naive and GC B Cells from B1–8(TG) Mice (A) Representative flow cytometry analysis of NP-specific naive and GC B cell populations. Rectangles indicate gates used to sort naive and germinal center B cells from unimmunized and immunized mice, respectively. (B) Relative mRNA expression of Igλ and AID in naive and GC B cells was determined by quantitative reverse-transcriptase PCR. The values of Igλ and AID transcripts were normalized to mb1 and the normalized value for naive B cells was set to one. Values represent the mean of three independent experiments, and error bars indicate the standard deviation. (C) Genomic DNA was isolated from NP-specific naive and GC B cells. The rearranged VJλ1 and Cλ1 regions were PCR amplified, cloned, and sequenced. Each wedge of a pie chart shows the proportion of sequences containing the indicated number or range of mutations. The number in the middle of each chart denotes the number of sequences analyzed. The mutation frequency (total number of mutations/total number of base pairs sequenced) is indicated below each pie chart. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 2 H3 and H4 Acetylation and H3-K4 Methylation at the Igλ Locus in Naive and GC B Cells (A) Schematic of the Igλ locus with a VJλ1 rearrangement. Regions analyzed by PCR are denoted by small black bars and are referred to in this and subsequent figures by the reference number below each bar. (B–D) H3 acetylation (B) H4 acetylation (C) and H3-K4 methylation (D) at Igλ in day 14 and day 10 GC B cells and naive B cells as assessed by ChIP. The AID enhancer and a region within the coding region of β-globin were evaluated as controls. Relative IP efficiency was determined as described in Experimental Procedures. Each bar indicates the mean of the values obtained from three experiments with standard deviation. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 3 The CpG Methylation Status of VJλ1 in Naive and Day 14 GC B Cells The four CpG motifs in the rearranged VJλ1 are indicated by the numbered vertical bars. Forty sequences from both day 14 GC B cells and naive B cells were analyzed and the percent demethylation at each of the four CpG motifs is shown for each cell population. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 4 H3 and H4 Acetylation at the IgH Locus in Naive and GC B Cells (A) Schematic of the IgH locus with the VH(KI) rearrangement. Small black bars indicate the locations of the regions analyzed by PCR: rearranged VH(KI), Eμ, Sμ, and Cμ. Arrows indicate approximate locations of transcription start sites. (B–C) H3 acetylation (B) and H4 acetylation (C) at IgH in day 14 GC B cells and naive B cells from B1–8(KI) mice as assessed by ChIP. The β-globin gene was evaluated as a negative control. Relative IP efficiency was determined as described in Experimental Procedures. With the exception of Sμ, each bar indicates the mean of the values obtained from three experiments with standard deviation. The relative IP efficiency of Sμ was determined as the mean of values from two experiments with the range of values shown by the error bar. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 5 γ-H2AX at Igλ and IgH in GC and Naive B Cells (A) γ-H2AX on Igλ in day 10 and day 14 GC B cells as assessed by ChIP. Regions amenable to Taqman qPCR analysis (Figure 2A) are shown in the bar graph. γ-H2AX is known to be associated with Sμ in activated B cells, and so Sμ (Figure 4A) serves as a positive control. Each bar indicates the mean Relative IP Efficiency for three experiments, and the standard deviation is shown. (B) Dilution PCR analysis of ChIP for γ-H2AX at region 1 of VJλ1, Sμ, and mb-1 promoter. Data shown are representative of at least two independent experiments. Region 1 (Figure 2A) spans the VJλ1 junction and could only be analyzed by semiquantitative PCR. Four 3-fold titrations are shown for input, IP, and no-antibody control samples. Sμ and the mb1 promoter were included as positive and negative controls, respectively. To show that γ-H2AX is associated with Sμ in GC but not naive B cells, a representative PCR analysis of a ChIP of naive B cells is shown. (C) γ-H2AX on IgH in naive and day 10 GC B cells as assessed by ChIP. Locations of the regions analyzed are depicted in Figure 4A. Each bar indicates the mean Relative IP Efficiency of three experiments, and the standard deviation is shown. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 6 H2BSer14P at Igλ and IgH in GC and Naive B Cells (A) H2BSer14P at Igλ was assessed by ChIP in naive B cells and day 10 and day 14 GC B cells isolated from aicda+/+ B1–8(Tg) mice and day 10 GC B cells from aicda−/− B1–8(Tg) mice. The Relative IP Efficiency of Sμ and Igλ regions amenable to Taqman analysis (Figures 2A and 4A) are shown in the bar graph. Each bar indicates the mean relative IP efficiency of three experiments, and the standard deviation is indicated. Since H2BSer14P is not expected to be associated with mb1, a relative IP efficiency value that is equal to or less than one reflects the nonspecific background of the assay (see Experimental Procedures). (B) Dilution PCR analysis of ChIP for H2BSer14P at region 1 of VJλ1 and mb-1. Data shown are representative of at least two experiments. ChIP analyses were performed on samples from naive and day 10 GC B cells from aicda+/+ B1–8(Tg) mice and day 10 GC B cells from aicda−/− B1–8(Tg) mice. Three 3-fold titrations are shown for input, IP, and no antibody control samples. mb1 was included as a negative control. (C) H2BSer14P at IgH was assessed by ChIP in naive and day 10 and day 14 GC B cells isolated from B1–8(KI) mice. The locations of the regions of IgH analyzed are depicted in Figure 4A. Each bar indicates the mean relative IP efficiency of three experiments, and the standard deviation is shown. Relative IP efficiency values equal to or less than one reflect the nonspecific background associated with the assay. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 7 Mst1 at Igλ and IgH in GC and Naive B Cells (A) ChIP was used to analyze the association of Mst1 with Igλ. The relative IP efficiency from four independent experiments using day 10 GC B cells (closed circles) and three independent experiments with naive B cells (open circles) is shown in the scatter plot with the mean for each indicated with a black bar. Since Mst1 is not expected to be associated with mb1, a relative IP efficiency value that is equal to or less than one reflects the nonspecific background of the assay. The regions analyzed are depicted in Figure 2A. (B) Dilution PCR analysis of ChIP for Mst1 at region 1 of VJλ1 and mb-1. Data shown are representative of at least two experiments. The mb1 promoter was included as a negative control. Three 3-fold titrations are shown for input, IP, and no antibody control samples from naive and day 10 GC B cells. (C) Mst1 association with IgH was analyzed by ChIP using B1–8(KI) mice. The scatter plot shows the relative IP efficiency from four independent experiments using day 10 GC B cells (closed circles) and three independent experiments using naive B cells (open circles) with the mean for each indicated with a black bar. Relative IP efficiency values equal to or less than one reflect the nonspecific background associated with the assay (see Experimental Procedures). Figure 4A shows the locations of the regions analyzed. Immunity 2005 23, 101-110DOI: (10.1016/j.immuni.2005.05.007) Copyright © 2005 Elsevier Inc. Terms and Conditions